Dr. Sanaz N. Soltani

Nadia Ramdin is a Hematologist Oncology specialist and an Oncologist in Danville, Pennsylvania. Dr. Ramdin is rated as a Distinguished provider by MediFind in the treatment of Sertoli-Leydig Cell Tumor. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Pancreatic Cancer, and Adenoid Cystic Carcinoma.

Mark Miller, DO, specializes in gynecologic oncology and obstetrics and gynecology and practices at PinnacleHealth Women's Cancer Center. He is affiliated with UPMC Williamsport. He completed his residency at Philadelphia College of Osteopathic Medicine and medical degree at Lake Erie College of Osteopathic Medicine. Dr. Miller is rated as a Distinguished provider by MediFind in the treatment of Sertoli-Leydig Cell Tumor. His top areas of expertise are Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, Malignant Mixed Mullerian Tumor, and Endometrial Cancer.

Joshua Kesterson, MD, is a fellowship-trained gynecologic oncologist and medical director of the gynecologic oncology program at UPMC in Central Pa. He received his medical degree from the University of Missouri and completed his residency in obstetrics, gynecology and women’s health at the University of Louisville, followed by his fellowship in gynecologic oncology at Roswell Park Cancer Institute. He is board-certified in obstetrics and gynecology and gynecologic oncology by the American Board of Obstetrics and Gynecology. Dr. Kesterson’s clinical interests include gynecologic oncology such as ovarian, cervical, and endometrial cancer, immunotherapy, and HPV, and his research interests include quality improvement, ovarian cancer, and endometrial carcinoma. He is a member of the Society for Gynecologic Oncologists, the Foundation for Women’s Cancer, and Alpha Omega Alpha Honor Society. Dr. Kesterson is rated as a Distinguished provider by MediFind in the treatment of Sertoli-Leydig Cell Tumor. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Oophorectomy.